Reports Q1 revenue $59.9M, consensus $57.43M. “Our momentum is accelerating across both the United States and OUS markets,” said Peter Caldini, Chief Executive Officer. “The U.S. launch of our minimally invasive platform is off to a strong start and is contributing meaningfully to our growth; we now expect it to make up at least 13% of 2026 revenue, up from previous guidance. At the same time, we’ve delivered our third consecutive quarter of positive adjusted EBITDA, underscoring the strength of our execution and the operational leverage inherent to this business.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ESTA:
- TD Cowen Reiterates Buy on Establishment Labs, Maintains $95 Price Target on Strong Growth and Profitability Trajectory
- Buy Rating Reaffirmed on Strong 2026 Outlook and Preservé Adoption; $86 Price Target Maintained
- Establishment Labs Amends Credit Agreement, Secures New Financing
- Establishment Labs refinances credit facility
- Short Report: Asana short interest at record high